{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T00:05:08Z","timestamp":1794960308890,"version":"4.9.1"},"reference-count":127,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>\n                    Graves\u2019 orbitopathy (GO), also known as thyroid-associated ophthalmopathy, is the most common ocular abnormality of Graves\u2019 disease. It is a disfiguring, invalidating, and potentially blinding orbital disease mediated by an interlocking and complicated immune network. Self-reactive T cells directly against thyroid-stimulating hormone receptor-bearing orbital fibroblasts contribute to autoimmune inflammation and tissue remodeling in GO orbital connective tissues. To date, T helper (Th) 1 (cytotoxic leaning) and Th2 (antibody leaning) cell subsets and an emerging role of Th17 (fibrotic leaning) cells have been implicated in GO pathogenesis. The potential feedback loops between orbital native residential CD34\n                    <jats:sup>-<\/jats:sup>\n                    fibroblasts, CD34\n                    <jats:sup>+<\/jats:sup>\n                    infiltrating fibrocytes, and effector T cells may affect the T cell subset bias and the skewed pattern of cytokine production in the orbit, thereby determining the outcomes of GO autoimmune reactions. Characterization of the T cell subsets that drive GO and the cytokines they express may significantly advance our understanding of orbital autoimmunity and the development of promising therapeutic strategies against pathological T cells.\n                  <\/jats:p>","DOI":"10.3389\/fendo.2021.648732","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T04:12:53Z","timestamp":1617250373000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":87,"title":["Mechanisms That Underly T Cell Immunity in Graves\u2019 Orbitopathy"],"prefix":"10.3389","volume":"12","author":[{"given":"Sijie","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazhuo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianqun","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13023-017-0625-1","article-title":"Graves\u2019 orbitopathy as a rare disease in Europe: a European Group on Graves\u2019 Orbitopathy (EUGOGO) position statement","volume":"12","author":"Perros","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1510030","article-title":"Graves\u2019 Disease","volume":"375","author":"Smith","year":"2016","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1159\/000509615","article-title":"Oxidative Stress in Graves Disease and Graves Orbitopathy","volume":"9","author":"Lanzolla","year":"2020","journal-title":"Eur Thyroid J"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(16)30046-8","article-title":"Advances in treatment of active, moderate-to-severe Graves\u2019 ophthalmopathy","volume":"5","author":"Wiersinga","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41572-020-0184-y","article-title":"Graves\u2019 disease","volume":"6","author":"Davies","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-018-0279-9","article-title":"The involvement of T cell pathogenesis in thyroid-associated ophthalmopathy","volume":"33","author":"Huang","year":"2019","journal-title":"Eye (Lond)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-018-1045-9","article-title":"Current and Emerging Treatment Strategies for Graves\u2019 Orbitopathy","volume":"79","author":"Genere","year":"2019","journal-title":"Drugs"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-019-0305-4","article-title":"New insights into the pathogenesis and nonsurgical management of Graves orbitopathy","volume":"16","author":"Taylor","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"B9","article-title":"Immunohistochemical analysis of the retrobulbar tissues in Graves\u2019 ophthalmopathy","volume":"75","author":"Weetman","year":"1989","journal-title":"Clin Exp Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/nri3803","article-title":"A brief history of T cell help to B cells","volume":"15","author":"Crotty","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-018-0315-9","article-title":"Interruption of autoimmunity for thyroid eye disease: B-cell and T-cell strategy","volume":"33","author":"Strianese","year":"2019","journal-title":"Eye (Lond)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.81.10.8855831","article-title":"Antigen receptor variable region repertoires expressed by T cells infiltrating thyroid, retroorbital, and pretibial tissue in Graves\u2019 disease","volume":"81","author":"Heufelder","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.84.5.517","article-title":"T cells and fibroblasts in affected extraocular muscles in early and late thyroid associated ophthalmopathy","volume":"84","author":"Pappa","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2018.0806","article-title":"Association of T and B Cells Infiltrating Orbital Tissues With Clinical Features of Graves Orbitopathy","volume":"136","author":"Rotondo Dottore","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e218","DOI":"10.1002\/ctm2.218","article-title":"Predicting the early risk of ophthalmopathy in Graves\u2019 disease patients using TCR repertoire","volume":"10","author":"Wang","year":"2020","journal-title":"Clin Transl Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.85.2.6333","article-title":"Relationship between disease duration and predominant orbital T cell subset in Graves\u2019 ophthalmopathy","volume":"85","author":"Aniszewski","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.05-0605","article-title":"Autologous T-lymphocytes stimulate proliferation of orbital fibroblasts derived from patients with Graves\u2019 ophthalmopathy","volume":"46","author":"Feldon","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.08-2328","article-title":"Orbital fibroblasts from patients with thyroid-associated ophthalmopathy overexpress CD40: CD154 hyperinduces IL-6, IL-8, and MCP-1","volume":"50","author":"Hwang","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-2697","article-title":"Orbit-infiltrating mast cells, monocytes, and macrophages produce PDGF isoforms that orchestrate orbital fibroblast activation in Graves\u2019 ophthalmopathy","volume":"97","author":"van Steensel","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.6.4397","article-title":"Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves\u2019 disease","volume":"181","author":"Tsui","year":"2008","journal-title":"J Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.45.29615","article-title":"Activation of human orbital fibroblasts through CD40 engagement results in a dramatic induction of hyaluronan synthesis and prostaglandin endoperoxide H synthase-2 expression. Insights into potential pathogenic mechanisms of thyroid-associated ophthalmopathy","volume":"273","author":"Cao","year":"1998","journal-title":"J Biol Chem"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63488-8","article-title":"Thy-1 expression in human fibroblast subsets defines myofibroblastic or lipofibroblastic phenotypes","volume":"163","author":"Koumas","year":"2003","journal-title":"Am J Pathol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-1689","article-title":"Interferon-gamma-inducible alpha-chemokine CXCL10 involvement in Graves\u2019 ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists","volume":"91","author":"Antonelli","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-2450","article-title":"Monokine induced by interferon gamma (IFNgamma) (CXCL9) and IFNgamma inducible T-cell alpha-chemoattractant (CXCL11) involvement in Graves\u2019 disease and ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists","volume":"94","author":"Antonelli","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1210\/en.2005-1018","article-title":"T helper type 1 and type 2 cytokines exert divergent influence on the induction of prostaglandin E2 and hyaluronan synthesis by interleukin-1beta in orbital fibroblasts: implications for the pathogenesis of thyroid-associated ophthalmopathy","volume":"147","author":"Han","year":"2006","journal-title":"Endocrinology"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.5.3072","article-title":"Induction by IL-1 beta of tissue inhibitor of metalloproteinase-1 in human orbital fibroblasts: modulation of gene promoter activity by IL-4 and IFN-gamma","volume":"174","author":"Han","year":"2005","journal-title":"J Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-2190","article-title":"Interleukin (IL)-23 receptor is a major susceptibility gene for Graves\u2019 ophthalmopathy: the IL-23\/T-helper 17 axis extends to thyroid autoimmunity","volume":"93","author":"Huber","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-1614","article-title":"Increased generation of fibrocytes in thyroid-associated ophthalmopathy","volume":"95","author":"Douglas","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-2514","article-title":"Increased expression of TSH receptor by fibrocytes in thyroid-associated ophthalmopathy leads to chemokine production","volume":"97","author":"Gillespie","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-01349","article-title":"Regulation of Orbital Fibrosis and Adipogenesis by Pathogenic Th17 Cells in Graves Orbitopathy","volume":"102","author":"Fang","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-01626","article-title":"Insights Into Local Orbital Immunity: Evidence for the Involvement of the Th17 Cell Pathway in Thyroid-Associated Ophthalmopathy","volume":"104","author":"Fang","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.18-24008","article-title":"Interaction Between CCR6+ Th17 Cells and CD34+ Fibrocytes Promotes Inflammation: Implications in Graves\u2019 Orbitopathy in Chinese Population","volume":"59","author":"Fang","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa124","article-title":"Evidence for Associations Between Th1\/Th17 \u201cHybrid\u201d Phenotype and Altered Lipometabolism in Very Severe Graves Orbitopathy","volume":"105","author":"Fang","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1900434","article-title":"Slit2 May Underlie Divergent Induction by Thyrotropin of IL-23 and IL-12 in Human Fibrocytes","volume":"204","author":"Fernando","year":"2020","journal-title":"J Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1210\/en.2013-1576","article-title":"Cutting edge: retrobulbar inflammation, adipogenesis, and acute orbital congestion in a preclinical female mouse model of Graves\u2019 orbitopathy induced by thyrotropin receptor plasmid-in vivo electroporation","volume":"154","author":"Moshkelgosha","year":"2013","journal-title":"Endocrinology"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2020.0088","article-title":"A Promising Mouse Model of Graves\u2019 Orbitopathy Induced by Adenovirus Expressing Thyrotropin Receptor A Subunit","author":"Zhang","year":"2020","journal-title":"Thyroid"},{"key":"B37","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s40168-018-0478-4","article-title":"INDIGO consortium. Gut microbiota in experimental murine model of Graves\u2019 orbitopathy established in different environments may modulate clinical presentation of disease","volume":"6","author":"Masetti","year":"2018","journal-title":"Microbiome"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.77.5.8077301","article-title":"Cytolytic T cells with Th1-like cytokine profile predominate in retroorbital lymphocytic infiltrates of Graves\u2019 ophthalmopathy","volume":"77","author":"de Carli","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117289","article-title":"Retrobulbar T cells from patients with Graves\u2019 ophthalmopathy are CD8+ and specifically recognize autologous fibroblasts","volume":"93","author":"Grubeck-Loebenstein","year":"1994","journal-title":"J Clin Invest"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.81.8.8768872","article-title":"Orbital tissue-derived T lymphocytes from patients with Graves\u2019 ophthalmopathy recognize autologous orbital antigens","volume":"81","author":"Otto","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1997.4491347.x","article-title":"Analysis of extraocular muscle-infiltrating T cells in thyroid-associated ophthalmopathy (TAO)","volume":"109","author":"Pappa","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1998.00613.x","article-title":"Analysis of orbital T cells in thyroid-associated ophthalmopathy","volume":"112","author":"F\u00f6rster","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/340934","article-title":"Disturbances of modulating molecules (FOXP3, CTLA-4\/CD28\/B7, and CD40\/CD40L) mRNA expressions in the orbital tissue from patients with severe graves\u2019 ophthalmopathy","volume":"2015","author":"Pawlowski","year":"2015","journal-title":"Mediators Inflamm"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-1882","article-title":"IL-17A Exacerbates Fibrosis by Promoting the Proinflammatory and Profibrotic Function of Orbital Fibroblasts in TAO","volume":"101","author":"Fang","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.16-20199","article-title":"IL-17A Promotes RANTES Expression, But Not IL-16, in Orbital Fibroblasts Via CD40-CD40L Combination in Thyroid-Associated Ophthalmopathy","volume":"57","author":"Fang","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2018.0754","article-title":"Fingolimod Improves the Outcome of Experimental Graves\u2019 Disease and Associated Orbitopathy by Modulating the Autoimmune Response to the Thyroid-Stimulating Hormone Receptor","volume":"29","author":"Pl\u00f6hn","year":"2019","journal-title":"Thyroid"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13075","article-title":"Genetic immunization with mouse thyrotrophin hormone receptor plasmid breaks self-tolerance for a murine model of autoimmune thyroid disease and Graves\u2019 orbitopathy","volume":"191","author":"Schl\u00fcter","year":"2018","journal-title":"Clin Exp Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"7329","DOI":"10.1038\/s41598-020-64402-9","article-title":"Enhanced orbital adipogenesis in a mouse model of T-cell-mediated autoimmunity, zymosan A-treated SKG mice: Implications for Graves\u2019 ophthalmopathy","volume":"10","author":"Park","year":"2020","journal-title":"Sci Rep"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1320266","article-title":"Analysis of retroorbital T cell antigen receptor variable region gene usage in patients with Graves\u2019 ophthalmopathy","volume":"132","author":"Heufelder","year":"1995","journal-title":"Eur J Endocrinol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1211709","article-title":"Molecular analysis of antigen receptor variable region repertoires in T lymphocytes infiltrating the intrathyroidal and extrathyroidal manifestations in patients with Graves\u2019 disease","author":"Heufelder","year":"1996","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1998.8.419","article-title":"T-cell restriction in thyroid eye disease","volume":"8","author":"Heufelder","year":"1998","journal-title":"Thyroid"},{"key":"B52","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.162.8.4966","article-title":"Development of an animal model of autoimmune thyroid eye disease","volume":"162","author":"Many","year":"1999","journal-title":"J Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1210\/en.2015-1829","article-title":"Comparative Assessment of Female Mouse Model of Graves\u2019 Orbitopathy Under Different Environments, Accompanied by Proinflammatory Cytokine and T-Cell Responses to Thyrotropin Hormone Receptor Antigen","volume":"157","author":"Berchner-Pfannschmidt","year":"2016","journal-title":"Endocrinology"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1994.tb06562.x","article-title":"T cell responses to orbital antigens in thyroid-associated ophthalmopathy","volume":"96","author":"Arnold","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1994.4.161","article-title":"Cellular immunity and retrobulbar fibroblasts in Graves\u2019 ophthalmopathy","volume":"4","author":"Stover","year":"1994","journal-title":"Thyroid"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2003.035915","article-title":"Thyroid associated ophthalmopathy: evidence for CD4(+) gammadelta T cells; de novo differentiation of RFD7(+) macrophages, but not of RFD1(+) dendritic cells; and loss of gammadelta and alphabeta T cell receptor expression","volume":"88","author":"Eckstein","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1210\/en.2016-1304","article-title":"Pathogenic Phenotype of Adipogenesis and Hyaluronan in Orbital Fibroblasts From Female Graves\u2019 Orbitopathy Mouse Model","volume":"157","author":"G\u00f6rtz","year":"2016","journal-title":"Endocrinology"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1001\/archopthalmol.2011.1215","article-title":"Small dose of rituximab for graves orbitopathy: new insights into the mechanism of action","volume":"130","author":"Salvi","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"37","DOI":"10.5603\/FHC.a2020.0003","article-title":"Search of reference biomarkers reflecting orbital tissue remodeling in the course of Graves\u2019 orbitopathy","volume":"58","author":"Pawlowski","year":"2020","journal-title":"Folia Histochem Cytobiol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ophtha.2009.05.029","article-title":"Rituximab treatment of patients with severe, corticosteroid-resistant thyroid-associated ophthalmopathy","volume":"117","author":"Khanna","year":"2010","journal-title":"Ophthalmology"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mce.2017.01.014","article-title":"Orbital fibroblasts of Graves\u2019 orbitopathy stimulated with proinflammatory cytokines promote B cell survival by secreting BAFF","volume":"446","author":"Tang","year":"2017","journal-title":"Mol Cell Endocrinol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2008.03219.x","article-title":"Role of macrophage infiltration in the orbital fat of patients with Graves\u2019 ophthalmopathy","volume":"69","author":"Chen","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B63","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.exer.2016.05.005","article-title":"Histamine induces NF-\u03baB controlled cytokine secretion by orbital fibroblasts via histamine receptor type-1","volume":"147","author":"Virakul","year":"2016","journal-title":"Exp Eye Res"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2007.0407","article-title":"Immune mechanisms in thyroid eye disease","volume":"18","author":"Lehmann","year":"2008","journal-title":"Thyroid"},{"key":"B65","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12967-018-1536-1","article-title":"Fibroblasts as a practical alternative to mesenchymal stem cells","volume":"16","author":"Ichim","year":"2018","journal-title":"J Transl Med"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-020-01341-2","article-title":"Putative protective role of autoantibodies against the insulin-like growth factor-1 receptor in Graves\u2019 Disease: results of a pilot study","volume":"43","author":"Lanzolla","year":"2020","journal-title":"J Endocrinol Invest"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-018-0943-8","article-title":"Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves\u2019 disease and Graves\u2019 orbitopathy","volume":"42","author":"Marin\u00f2","year":"2019","journal-title":"J Endocrinol Invest"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2017.12.001","article-title":"Activation of thyroid antigen-reactive B cells in recent onset autoimmune thyroid disease patients","volume":"89","author":"Smith","year":"2018","journal-title":"J Autoimmun"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-018-0285-y","article-title":"B cells in Graves\u2019 Orbitopathy: more than just a source of antibodies","volume":"33","author":"Salvi","year":"2019","journal-title":"Eye (Lond)"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-00816-x","article-title":"The immunology of rheumatoid arthritis","volume":"22","author":"Weyand","year":"2020","journal-title":"Nat Immunol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.4103\/tjo.tjo_18_20","article-title":"Progress in the pathogenesis of thyroid-associated ophthalmopathy and new drug development","volume":"10","author":"Huang","year":"2020","journal-title":"Taiwan J Ophthalmol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2017.00028","article-title":"TSH Receptor Antibody Functionality and Nomenclature","volume":"8","author":"Kahaly","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B73","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.exer.2015.02.007","article-title":"Current perspectives on the role of orbital fibroblasts in the pathogenesis of Graves\u2019 ophthalmopathy","volume":"142","author":"Dik","year":"2016","journal-title":"Exp Eye Res"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2016.00167","article-title":"Building the Case for Insulin-Like Growth Factor Receptor-I Involvement in Thyroid-Associated Ophthalmopathy","volume":"7","author":"Smith","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107502","article-title":"TSH\/IGF1 receptor crosstalk: Mechanism and clinical implications","volume":"209","author":"Krieger","year":"2020","journal-title":"Pharmacol Ther"},{"key":"B76","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/0090-1229(95)90135-3","article-title":"CD40 expression by human fibroblasts","volume":"77","author":"Fries","year":"1995","journal-title":"Clin Immunol Immunopathol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.1998.274.3.C707","article-title":"Human orbital fibroblasts are activated through CD40 to induce proinflammatory cytokine production","volume":"274","author":"Sempowski","year":"1998","journal-title":"Am J Physiol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.09-3789","article-title":"The expression of intercellular adhesion molecule-1 induced by CD40-CD40L ligand signaling in orbital fibroblasts in patients with Graves\u2019 ophthalmopathy","volume":"51","author":"Zhao","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-014-2902-1","article-title":"CD40 ligand induces expression of vascular cell adhesion molecule 1 and E-selectin in orbital fibroblasts from patients with Graves\u2019 orbitopathy","volume":"253","author":"Wang","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.18-25466","article-title":"CD40 Enhances Sphingolipids in Orbital Fibroblasts: Potential Role of Sphingosine-1-Phosphate in Inflammatory T-Cell Migration in Graves\u2019 Orbitopathy","volume":"59","author":"Pl\u00f6hn","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2006.060434","article-title":"Activated human T lymphocytes express cyclooxygenase-2 and produce proadipogenic prostaglandins that drive human orbital fibroblast differentiation to adipocytes","volume":"169","author":"Feldon","year":"2006","journal-title":"Am J Pathol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1999.9.305","article-title":"Dominant infiltration of T(H)1-type CD4+ T cells at the retrobulbar space of patients with thyroid-associated ophthalmopathy","volume":"9","author":"Yang","year":"1999","journal-title":"Thyroid"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.85.3.6433","article-title":"Cytokine profiles in eye muscle tissue and orbital fat tissue from patients with thyroid-associated ophthalmopathy","volume":"85","author":"Hiromatsu","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2003.01708.x","article-title":"TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves\u2019 ophthalmopathy patients","volume":"58","author":"Wakelkamp","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(200202)32:2<477::AID-IMMU477>3.0.CO;2-U","article-title":"Fibroblast subsets in the human orbit: Thy-1+ and Thy-1- subpopulations exhibit distinct phenotypes","volume":"32","author":"Koumas","year":"2002","journal-title":"Eur J Immunol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1097\/00002341-199803000-00008","article-title":"Interleukin-8 and monocyte chemotactic protein-1 gene expression and protein production by human orbital fibroblasts","volume":"14","author":"Elner","year":"1998","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-11-0488","article-title":"\u03b2 (CCL2) and \u03b1 (CXCL10) chemokine modulations by cytokines and peroxisome proliferator-activated receptor-\u03b1 agonists in Graves\u2019 ophthalmopathy","volume":"213","author":"Antonelli","year":"2012","journal-title":"J Endocrinol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.175.2.1310","article-title":"IL-1 beta induces IL-6 expression in human orbital fibroblasts: identification of an anatomic-site specific phenotypic attribute relevant to thyroid-associated ophthalmopathy","volume":"175","author":"Chen","year":"2005","journal-title":"J Immunol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2011.11.001","article-title":"Peroxisome proliferator-activated receptor-\u03b1 agonists modulate CXCL9 and CXCL11 chemokines in Graves\u2019 ophthalmopathy fibroblasts and preadipocytes","volume":"349","author":"Antonelli","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1316352","article-title":"Circulating CXCL9 and CXCL10 as markers of activity of Graves\u2019 orbitopathy during treatment with corticosteroids and teleradiotherapy","volume":"44","author":"Mysliwiec","year":"2012","journal-title":"Horm Metab Res"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz289","article-title":"Th1 Chemokines in Autoimmune Endocrine Disorders","volume":"105","author":"Fallahi","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B92","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s13287-019-1348-0","article-title":"Human placenta-derived mesenchymal stem cells ameliorate orbital adipogenesis in female mice models of Graves\u2019 ophthalmopathy","volume":"10","author":"Park","year":"2019","journal-title":"Stem Cell Res Ther"},{"key":"B93","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nri.2017.90","article-title":"Type 2 immunity in tissue repair and fibrosis","volume":"18","author":"Gieseck","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-012-2092-7","article-title":"Increased serum interleukin-17 in Graves\u2019 ophthalmopathy","volume":"250","author":"Kim","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/609593","article-title":"Th1, Th2, and Th17 Cytokine Involvement in Thyroid Associated Ophthalmopathy","volume":"2015","author":"Shen","year":"2015","journal-title":"Dis Markers"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.ej14-0246","article-title":"Circulating levels of miR-146a and IL-17 are significantly correlated with the clinical activity of Graves\u2019 ophthalmopathy","volume":"61","author":"Wei","year":"2014","journal-title":"Endocr J"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-011-1863-x","article-title":"Inflammatory cytokine profiles in the tears of thyroid-associated ophthalmopathy","volume":"250","author":"Huang","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2011.0248","article-title":"Graves\u2019 orbitopathy results in profound changes in tear composition: a study of plasminogen activator inhibitor-1 and seven cytokines","volume":"22","author":"Ujhelyi","year":"2012","journal-title":"Thyroid"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.13-13704","article-title":"Changes of lacrimal gland and tear inflammatory cytokines in thyroid-associated ophthalmopathy","volume":"55","author":"Huang","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2017.12.007","article-title":"A cellular and molecular view of T helper 17 cell plasticity in autoimmunity","volume":"87","author":"Stadhouders","year":"2018","journal-title":"J Autoimmun"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.50","article-title":"The dichotomous nature of T helper 17 cells","volume":"17","author":"Stockinger","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1089\/thy.2008.0423","article-title":"Increases of the Th1\/Th2 cell ratio in severe Hashimoto\u2019s disease and in the proportion of Th17 cells in intractable Graves\u2019 disease","volume":"19","author":"Nanba","year":"2009","journal-title":"Thyroid"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/8431838","article-title":"Increased Circulating Th17 but Decreased CD4+Foxp3+ Treg and CD19+CD1dhiCD5+ Breg Subsets in New-Onset Graves\u2019 Disease","volume":"2017","author":"Qin","year":"2017","journal-title":"BioMed Res Int"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-017-1361-y","article-title":"Pathogenic Th17 and Th22 cells are increased in patients with autoimmune thyroid disorders","volume":"57","author":"Vitales-Noyola","year":"2017","journal-title":"Endocrine"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2014.226","article-title":"TSH-receptor-expressing fibrocytes and thyroid-associated ophthalmopathy","volume":"11","author":"Smith","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-01493","article-title":"Potential Roles of CD34+ Fibrocytes Masquerading as Orbital Fibroblasts in Thyroid-Associated Ophthalmopathy","volume":"104","author":"Smith","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1202064109","article-title":"Human fibrocytes coexpress thyroglobulin and thyrotropin receptor","volume":"109","author":"Fernando","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1210\/en.2016-1382","article-title":"Intersection of Chemokine and TSH Receptor Pathways in Human Fibrocytes: Emergence of CXCL-12\/CXCR4 Cross Talk Potentially Relevant to Thyroid-Associated Ophthalmopathy","volume":"157","author":"Fernando","year":"2016","journal-title":"Endocrinology"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1249","article-title":"Fibroblasts expressing the thyrotropin receptor overarch thyroid and orbit in Graves\u2019 disease","volume":"96","author":"Smith","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.179317","article-title":"Peroxisome proliferator-activated receptor gamma ligands inhibit transforming growth factor-beta-induced, hyaluronan-dependent, T cell adhesion to orbital fibroblasts","volume":"286","author":"Guo","year":"2011","journal-title":"J Biol Chem"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1391","article-title":"Hyaluronan: from extracellular glue to pericellular cue","volume":"4","author":"Toole","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1172\/JCI16583","article-title":"A role for CD44 in an antigen-induced murine model of pulmonary eosinophilia","volume":"111","author":"Katoh","year":"2003","journal-title":"J Clin Invest"},{"key":"B113","doi-asserted-by":"publisher","first-page":"e0132479","DOI":"10.1371\/journal.pone.0132479","article-title":"Differences in CD44 Surface Expression Levels and Function Discriminates IL-17 and IFN-\u03b3 Producing Helper T Cells","volume":"10","author":"Schumann","year":"2015","journal-title":"PloS One"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.ai.2018.12.001","article-title":"Multilayer regulation of CD4 T cell subset differentiation in the era of single cell genomics","volume":"141","author":"Sungnak","year":"2019","journal-title":"Adv Immunol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jaut.2017.12.003","article-title":"TH17 cell plasticity: The role of dendritic cells and molecular mechanisms","volume":"87","author":"Agalioti","year":"2018","journal-title":"J Autoimmun"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.3109\/08916931003777247","article-title":"Distinct role of T helper Type 17 immune response for Graves\u2019 hyperthyroidism in mice with different genetic backgrounds","volume":"44","author":"Horie","year":"2011","journal-title":"Autoimmunity"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1055\/a-0653-3766","article-title":"Gut Microbiome in BALB\/c and C57BL\/6J Mice Undergoing Experimental Thyroid Autoimmunity Associate with Differences in Immunological Responses and Thyroid Function","volume":"50","author":"Moshkelgosha","year":"2018","journal-title":"Horm Metab Res"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa511","article-title":"Gut Dysbiosis Contributes to the Imbalance of Treg and Th17 Cells in Graves\u2019 Disease Patients by Propionic Acid","volume":"105","author":"Su","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2013.0396","article-title":"Thyrotropin acts as a T-cell developmental factor in mice and humans","volume":"24","author":"van der Weerd","year":"2014","journal-title":"Thyroid"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.5.3281","article-title":"Aberrant expression of the insulin-like growth factor-1 receptor by T cells from patients with Graves\u2019 disease may carry functional consequences for disease pathogenesis","volume":"178","author":"Douglas","year":"2007","journal-title":"J Immunol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-3207","article-title":"Rituximab (Rituxan) therapy for severe thyroid-associated ophthalmopathy diminishes IGF-1R(+) T cells","volume":"99","author":"McCoy","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.2.942","article-title":"Igs from patients with Graves\u2019 disease induce the expression of T cell chemoattractants in their fibroblasts","volume":"168","author":"Pritchard","year":"2002","journal-title":"J Immunol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2017.07.144","article-title":"Tim3\/galectin-9 alleviates the inflammation of TAO patients via suppressing Akt\/NF-kB signaling pathway","volume":"491","author":"Luo","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"B124","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2174\/1566524018666180705105753","article-title":"Decreased Expression of TIM-3 on Th17 Cells Associated with Ophthalmopathy in Patients with Graves\u2019 Disease","volume":"18","author":"Zhao","year":"2018","journal-title":"Curr Mol Med"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1800259","article-title":"Slit2 Modulates the Inflammatory Phenotype of Orbit-Infiltrating Fibrocytes in Graves\u2019 Disease","volume":"200","author":"Fernando","year":"2018","journal-title":"J Immunol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0000000000000402","article-title":"Update on Graves disease: advances in treatment of mild, moderate and severe thyroid eye disease","volume":"28","author":"Strianese","year":"2017","journal-title":"Curr Opin Ophthalmol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2019.0036","article-title":"Antigen-Specific Immunotherapy with Thyrotropin Receptor Peptides in Graves\u2019 Hyperthyroidism: A Phase I Study","volume":"29","author":"Pearce","year":"2019","journal-title":"Thyroid"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.648732\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T08:46:47Z","timestamp":1698828407000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.648732\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":127,"alternative-id":["10.3389\/fendo.2021.648732"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.648732","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,1]]},"article-number":"648732"}}